List view / Grid view
A new study has found that mycobacteria are associated with red blood cells at lung infection sites, an interaction that has escaped scientists for 140 years.
After two decades, researchers have generated the first complete, gapless sequence of a human genome
Scientists have opened a path towards triple-negative breast cancer treatment, by creating organoids from tumour samples.
A new study in zebrafish has shown the Hand2 protein may play a role in the origin of mesothelioma, presenting a target.
Pre-clinical research in newborn rats found that a nanotherapy could prevent chronic lung disease in premature babies.
New research has found that immune cells produce a chemical messenger that prevents heart disease–related inflammation
Scientists have developed a genetic screening platform to identify genes that can enhance immune cells to make them more persistent and increase their ability to eradicate tumour cells.
Researchers have developed a pH-sensitive drug delivery system in T cells using C-terminal dendrimers with Phenylalanine.
Genflow have announced a scientific research collaboration with the University of Rochester’s Aging Research Center. Together, they will study the ageing process in liver tissue.
Researchers have developed a new method to screen drugs for Alzheimer’s disease, shedding light on why current drugs have failed and identifying novel drug targets.
Pre-clinical research has found that CAR T cells can suppress gastrointestinal cancer cells without causing harm to healthy tissues.
Researchers have created an implantable biotechnology that produces and releases CAR T cells for attacking cancerous tumours.
Research in mice has shown that adding anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumour growth.
NanoTemper Technologies has announced the launch of Spectral Shift technology with its Dianthus instrument.
Sino Biological, Inc. has announced a new contract research services partnership with Ainnocence, Inc.
